David E. Reichman, M. D. , Stacey A. Missmer, Sc. D. , Katharine F

Slides:



Advertisements
Similar presentations
Lisa Marii Cookingham, M. D. , Rachel P. Goossen, B. A. , Amy E. T
Advertisements

Susannah Baruch, J.D., David Kaufman, Ph.D., Kathy L. Hudson, Ph.D. 
Krinos M. Trokoudes, M. D. , Constantinos Pavlides, M. Sc
A giant oocyte in a cohort of retrieved oocytes: does it have any effect on the in vitro fertilization cycle outcome?  Ronit Machtinger, M.D., Joseph.
Susannah Baruch, J.D., David Kaufman, Ph.D., Kathy L. Hudson, Ph.D. 
Age at menarche: a predictor of diminished ovarian function?
Daily physical activity and hot flashes in the Study of Women's Health Across the Nation (SWAN) Flashes Study  Carolyn Gibson, M.P.H., M.S., Karen Matthews,
Fernando Zegers-Hochschild, M.D.  Fertility and Sterility 
Michael M. Alper, M.D.  Fertility and Sterility 
Clinical application of oocyte vitrification: a systematic review and meta-analysis of randomized controlled trials  Ana Cobo, Ph.D., César Diaz, M.D. 
Can an educational DVD improve the acceptability of elective single embryo transfer? A randomized controlled study  Nicole Hope, M.B., B.S., Hon., Luk.
Cutoff value of human chorionic gonadotropin in relation to the number of methotrexate cycles in the successful treatment of ectopic pregnancy  Ewa Nowak-Markwitz,
What is the quality of information on social oocyte cryopreservation provided by websites of Society for Assisted Reproductive Technology member fertility.
Medical treatment of ectopic pregnancy: a committee opinion
Live birth of twins derived from zona-free oocytes
Grant D.E. McWilliams, D.O., John L. Frattarelli, M.D. 
How old is too old? Challenges faced by clinicians concerning age cutoffs for patients undergoing in vitro fertilization  Robert L. Klitzman, M.D.  Fertility.
Application of redefined human chorionic gonadotropin curves for the diagnosis of women at risk for ectopic pregnancy  Beata E. Seeber, M.D., Mary D.
Optimizing the number of blastocyst stage embryos to transfer on day 5 or 6 in women 38 years of age and older: a Society for Assisted Reproductive Technology.
Oocyte cryopreservation
How and when human chorionic gonadotropin curves in women with an ectopic pregnancy mimic other outcomes: differences by race and ethnicity  Katherine.
Alka Prakash, M. D. , Susan Laird, Ph. D. , Elizabeth Tuckerman, M. Sc
Establishing a human chorionic gonadotropin cutoff to guide methotrexate treatment of ectopic pregnancy: a systematic review  Seema Menon, M.D., John.
Lisa Marii Cookingham, M. D. , Rachel P. Goossen, B. A. , Amy E. T
Robert F. Casper, M.D.  Fertility and Sterility 
Association of the very early rise of human chorionic gonadotropin with adverse outcomes in singleton pregnancies after in vitro fertilization  Christopher.
Mieke Carine Wim Eeckhaut, Ph.D.  Fertility and Sterility 
Calculating cumulative live-birth rates from linked cycles of assisted reproductive technology (ART): data from the Massachusetts SART CORS  Judy E. Stern,
Limitations on the compensation of gamete donors: a public opinion survey  Malinda S. Lee, M.D., M.B.A., Leslie V. Farland, Sc.D., Stacey A. Missmer, Sc.D.,
A comparison of three downregulation approaches for poor responders undergoing in vitro fertilization  Laura Detti, M.D., Daniel B. Williams, M.D., Jared.
Association between prior appendectomy and/or tonsillectomy in women and subsequent pregnancy rate: a cohort study  Li Wei, Ph.D., Thomas MacDonald, M.D.,
Sean Ackerman, M. D. , Julia Wenegrat, M. A. , David Rettew, M. D
Early serum β-human chorionic gonadotropin in pregnancies after in vitro fertilization: contribution of treatment variables and prediction of long-term.
Patients with severe ovarian hyperstimulation syndrome can be managed safely with aggressive outpatient transvaginal paracentesis  Laura P. Smith, M.D.,
Management of tubal ectopic pregnancy: methotrexate and salpingostomy are preferred to preserve fertility  Stephanie Beall, M.D., Ph.D., Alan H. DeCherney,
Clomiphene citrate at 50: the dawning of assisted reproduction
Using the Society for Assisted Reproductive Technology Clinic Outcome System morphological measures to predict live birth after assisted reproductive.
Modulation of HOXA10 and other markers of endometrial receptivity by age and human chorionic gonadotropin in an endometrial explant model  Robin H. Fogle,
Spontaneous reduction before 12 weeks' gestation and selective reduction similarly extend time to delivery in in vitro fertilization of trichorionic-triamniotic.
Akanksha Mehta, M.D., Darius A. Paduch, M.D., Ph.D. 
Gonadotropin-releasing hormone antagonist use is associated with increased pregnancy rates in ovulation induction–intrauterine insemination to in vitro.
Changes in cytokine levels of patients with ovarian endometriosis after treatment with gonadotropin-releasing hormone analogue, ultrasound-guided drainage,
Efficacy and safety of human chorionic gonadotropin for follicular phase stimulation in assisted reproduction: a systematic review and meta-analysis 
One last chance for pregnancy: a review of 2,705 in vitro fertilization cycles initiated in women age 40 years and above  Sigal Klipstein, M.D., Meredith.
Efficacy of intrauterine inseminations as a training modality for performing embryo transfer in reproductive endocrinology and infertility fellowship.
Optimizing the number of cleavage stage embryos to transfer on day 3 in women 38 years of age and older: a Society for Assisted Reproductive Technology.
Fertility and Sterility
Aviad Cohen, M. D. , Guy Bibi, M. D. , Benny Almog, M. D
Zsolt P. Nagy, M. D. , Ph. D. , Laura F. Rienzi, Ph. D. , Filippo M
Vasiliki A. Moragianni, M. D. , M. S. , Stephanie-Marie L. Jones, M. D
Effectiveness of highly purified human menopausal gonadotropin vs
Geographic distribution of reproductive endocrinology and infertility (REI) fellowships in the United States  Mary E. Abusief, M.D., Stacey A. Missmer,
Cameron Gilbert, M. Sc. , Maria Valois, M. D. , FRCPC, Ph. D
Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin  Samuel S. Thatcher, M.D., Ph.D., Elizabeth M.
Are endometrial parameters by three-dimensional ultrasound and power Doppler angiography related to in vitro fertilization/embryo transfer outcome?  Luis.
Reducing the dose of human chorionic gonadotropin in high responders does not affect the outcomes of in vitro fertilization  David W. Schmidt, M.D.,,
Fertility and Sterility: an evaluation
Current evaluation of amenorrhea
Fertility and Sterility
A combined analysis of data to identify predictive factors for spermatogenesis in men with hypogonadotropic hypogonadism treated with recombinant human.
Aline Ketefian, M. D. , Jianfang Hu, Ph. D. , Alfred A. Bartolucci, Ph
Egg production predicts a doubling of in vitro fertilization pregnancy rates even within defined age and ovarian reserve categories  Melissa C. Yih, M.D.,
In vitro sildenafil citrate use as a sperm motility stimulant
Saad Elzanaty, M.D., Ph.D., Johan Malm, M.D., Ph.D. 
Krinos M. Trokoudes, M. D. , Constantinos Pavlides, M. Sc
Progesterone level and progesterone/estradiol ratio on the day of hCG administration: detrimental cutoff levels and new treatment strategy  Eman A. Elgindy,
A novel “delayed start” protocol with gonadotropin-releasing hormone antagonist improves outcomes in poor responders  Hakan Cakmak, M.D., Nam D. Tran,
Serum human chorionic gonadotropin level after ovulation triggering is influenced by the patient’s body mass index and the number of larger follicles 
Logarithmic curves depicting initial level and rise of serum beta human chorionic gonadotropin and live delivery outcomes with in vitro fertilization:
Hyperglycosylated human chorionic gonadotropin as an early predictor of pregnancy outcomes after in vitro fertilization  Sandy Chuan, M.D., Michael Homer,
Presentation transcript:

Effect of time between human chorionic gonadotropin injection and egg retrieval is age dependent  David E. Reichman, M.D., Stacey A. Missmer, Sc.D., Katharine F. Berry, M.A., Elizabeth S. Ginsburg, M.D., Catherine Racowsky, Ph.D.  Fertility and Sterility  Volume 95, Issue 6, Pages 1990-1995 (May 2011) DOI: 10.1016/j.fertnstert.2011.02.043 Copyright © 2011 American Society for Reproductive Medicine Terms and Conditions

Figure 1 Comparison of odds ratios (OR) for extended hCG exposure with respect to increasing patient age for clinical outcomes. Fertility and Sterility 2011 95, 1990-1995DOI: (10.1016/j.fertnstert.2011.02.043) Copyright © 2011 American Society for Reproductive Medicine Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.